APOE and Alzheimer disease: Compared to the most frequent allele APOE3, the carrier status of APOE4 can greatly increase the risk of AD by 3–4 times in heterozygotes and 15 times in homozygotes, while APOE ɛ2 can reduce the risk by 40% [6, 7].